Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…
A recent video presentation examines executive authority, industrial planning, and monetary leadership ahead of the nation’s 250th anniversary. Washington, D.C.,…